AVXL

In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Anavex Life Sciences (AVXL - Research Report), with a price target of $40.00. The company's shares closed today at $12.05.According to TipRanks, Palomeque is an analyst with an average return of -14.8% and a 32.14% success rate. Palomeque covers the Healthcare sector, focusing on stocks such as Ascendis Pharma, Denali Therapeutics, and Anavex Life Sciences.Anavex Life Sciences has an analyst consensus of Strong Buy, with a price target consensus of $49.25, representing a 308.71% upside. In a report released today, BTIG also reiterated a Buy rating on the stock with a $35.00 price target.
https://www.tipranks.com/news/blurbs/berenberg-bank-reaffirms-their-buy-rating-on-anavex-life-sciences-avxl?utm_source=advfn.com&utm_medium=referral